European Regulations

EMIR in the EEA 2026: new obligations for entities with derivatives in Norway, Iceland and Liechtenstein

E
Equipo Editorial CambiosLegales
Nov 18, 2026 6 min 14 views

Key data

RegulationCouncil Decision (EU) 2026/2553 of 9 November 2026 — EMIR CCP Regulation (Annex IX of the EEA Agreement)
Publication18 November 2026
Entry into forceNot specified in the regulation
Affected partiesFinancial entities, banks, funds and investment firms operating with derivatives in the EEA
CategoryEuropean Regulation
Geographic scopeNorway, Iceland and Liechtenstein (non-EU EEA countries)
Official referenceOJ:L_202602553
Impact analysis reserved for subscribers
The detailed impact analysis of this regulation is available with the PRO and Business plans. Access the full content and receive personalized alerts.
From €9.99/month · Cancel anytime

Financial entities with derivatives exposure in the European Economic Area face a significant change in rules. The Council Decision 2026/2553, published on 18 November 2026, sets the EU's position to amend Annex IX of the EEA Agreement and incorporate the EMIR Regulation on Central Counterparties (CCPs). The practical result: Norway, Iceland and Liechtenstein become subject to the same European obligations that already apply in the 27 EU member states.

If your entity operates with OTC derivatives, has exposure to clearing houses in these three countries or uses third-country CCPs recognized under EMIR, this regulation directly affects you.

What does this regulation establish?

The decision amends Annex IX (Financial Services) of the EEA Agreement to incorporate the EMIR Regulation on Central Counterparties. This means that the three non-EU EEA countries—Norway, Iceland and Liechtenstein—must transpose and apply the same European rules in four key areas:

Regulated areaWhat is required
OTC derivatives clearingObligation to clear through CCPs authorized under EMIR standards
Capital requirementsCCPs must maintain the capital levels required by the European framework
SupervisionCCPs in the EEA are subject to the EU's harmonized supervision regime
Third-country recognitionClearing houses outside the EEA must be recognized under EMIR criteria to operate in these markets

The stated objective of the measure is to strengthen systemic stability and reduce counterparty risk in EEA financial markets, creating a homogeneous regulatory space from the Atlantic to the Norwegian Arctic.

Economic and operational impact

The extension of EMIR to the EEA is not a cosmetic change. For entities with cross-border activity in Norway, Iceland or Liechtenstein, the operational impact translates into concrete obligations that may require investment in systems, processes and compliance resources.

  • Review of OTC derivatives contracts: Agreements with counterparties in the three EEA countries must be verified to confirm that clearing is carried out through CCPs recognized under EMIR.
  • Adaptation of reporting systems: Derivatives reporting obligations are aligned with the European standard, which may require adjustments to risk management platforms.
  • Review of third-country CCP recognition: If clearing houses outside the EEA are used, they must be recognized under EMIR criteria to remain valid.
  • Additional capital requirements: CCPs operating in the EEA must comply with European capital levels, which may affect access conditions and cost of clearing services.

The impact is particularly relevant for entities that until now operated under national regulatory frameworks in Norway, Iceland or Liechtenstein with standards different from European ones. Harmonization eliminates that regulatory advantage and levels the playing field, but also increases compliance costs.

Who does it affect?

  • Banks and credit institutions with OTC derivatives operations in Norway, Iceland or Liechtenstein.
  • Investment funds and asset managers that use derivatives for hedging or speculation with EEA exposure.
  • Investment firms that intermediate or execute derivatives operations in these markets.
  • Central Counterparties (CCPs) that operate or wish to operate in the EEA space.
  • Financial entities from third countries whose clearing houses must be recognized under EMIR to access the EEA.
  • Risk, compliance and treasury departments of any financial group with cross-border activity in the three affected countries.

Practical example

A Spanish bank with a subsidiary in Oslo that uses OTC derivatives—for example, interest rate swaps to hedge its loan portfolio—must ensure that those operations are cleared through a CCP recognized under EMIR. Until now, it could have operated under the Norwegian regulatory framework, which did not require exactly the same standards. With the incorporation of EMIR into the EEA Agreement, the Norwegian subsidiary becomes subject to the same clearing, reporting and capital obligations as any equivalent entity in Madrid, Frankfurt or Paris.

If the subsidiary uses a clearing house from a third country—for example, from the United States or United Kingdom—that CCP must be recognized under EMIR criteria for the operations to be valid. If it is not, the entity must migrate those operations to a recognized CCP or assume the risk of regulatory non-compliance.

Do you need to track this and other regulations?

Consult the full details on CambiosLegales

What should companies do now?

  1. Identify EEA exposure: Map all OTC derivatives operations with counterparties or through clearing houses in Norway, Iceland and Liechtenstein.
  2. Verify the status of CCPs used: Confirm that the Central Counterparties employed are authorized or recognized under the European EMIR framework.
  3. Review existing derivatives contracts: Analyze whether current agreements with counterparties in the EEA comply with the new clearing and reporting standards.
  4. Update reporting systems: Adapt risk management and derivatives reporting platforms to EMIR's harmonized requirements.
  5. Evaluate capital requirements: If the entity acts as a CCP or has holdings in CCPs in the EEA, review compliance with required capital levels.
  6. Coordinate with legal and compliance departments: Involve compliance teams to establish an adaptation plan with clear milestones, especially given that the entry into force date has not been specified and may be activated with little notice.

Frequently asked questions

Which countries are affected by the extension of EMIR to the EEA?

Decision 2026/2553 extends EMIR obligations to the three European Economic Area countries that are not EU members: Norway, Iceland and Liechtenstein. These countries must incorporate the EMIR Regulation on Central Counterparties (CCPs) into their legal systems by amending Annex IX of the EEA Agreement.

What specific obligations does EMIR impose on financial entities in the EEA?

Financial entities operating with OTC derivatives in the EEA are subject to four main obligations: clearing of OTC derivatives through authorized CCPs, compliance with capital requirements for CCPs, submission to the harmonized European supervision regime, and exclusive use of third-country CCPs that have been recognized under EMIR criteria.

When does this regulation enter into force?

The Decision was published on 18 November 2026, but the exact date of entry into force has not been specified in the regulation. This is common in EEA Joint Committee decisions, where effective implementation depends on formal incorporation by each country. It is recommended not to wait for the official date and to begin internal review immediately.

What happens if an entity uses a clearing house from a third country not recognized under EMIR?

Third-country CCPs—such as those from the United Kingdom or United States—must be recognized under EMIR criteria for operations cleared through them to be valid in the EEA. If an entity uses an unrecognized CCP, the operations may not meet the required clearing standards, which poses a regulatory compliance risk that must be resolved by migrating those operations to a recognized CCP.

Does this regulation affect non-financial companies that use derivatives for hedging?

The regulation is primarily aimed at financial entities: banks, funds and investment firms with derivatives exposure in the EEA. Non-financial companies that use derivatives exclusively for hedging commercial risks may fall outside the direct scope of application, but should verify whether their financial counterparties or the CCPs they use are affected, as this may impact the terms of their hedging contracts.

Official source

Consult full regulation at official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602553



Share:
E
Equipo Editorial CambiosLegales

El equipo editorial de CambiosLegales analiza diariamente los cambios normativos que afectan a empresas y autónomos en España, ofreciendo análisis pro...

Comments

No comments yet. Be the first to comment!

Leave a comment
Activate alerts

Almost there